Securities abbreviation: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) securities code: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) Announcement No.: 2022010 Jiangsu Kanion Pharmaceutical Co.Ltd(600557)
Announcement on the renewal of accounting firm
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Name of accounting firm to be renewed: Lixin Certified Public Accountants (special general partnership)
Jiangsu Kanion Pharmaceutical Co.Ltd(600557) (hereinafter referred to as “the company”) plans to renew the appointment of Lixin Certified Public Accountants (special general partnership) (hereinafter referred to as “Lixin”) as the company’s 2022 financial report audit institution and internal control audit institution for a period of one year, and the audit fee shall be determined by both parties through negotiation according to the audit workload. The specific contents are as follows: I. Basic information of the proposed accounting firm
(I) institutional information
1. Basic information
Lixin Certified Public Accountants (special general partnership) was founded in Shanghai in 1927 and reopened in 1986. In 2010, it became the first special general partnership certified public accountants firm in China to complete the restructuring, with its registered address in Shanghai. As a member of the international accounting network BDO, Lixin has been engaged in securities service business for a long time. Before the implementation of the new securities law, it has a securities and futures business license, has H-share audit qualification, and has been registered with the American public company accounting supervision board (PCAOB).
2. Personnel information
By the end of 2021, Lixin had 252 partners, 2276 certified public accountants, 9697 employees, and 707 certified public accountants who had signed the audit report of securities service business.
3. Business scale
In 2020, the business income (audited) of Lixin was 4.106 billion yuan, including 3.431 billion yuan from audit business and 1.357 billion yuan from securities business. In 2020, Lixin provided annual report audit services for 587 listed companies, with an audit fee of 719 million yuan and 398 audit customers of Listed Companies in the same industry.
4. Investor protection ability
By the end of 2021, Lixin had withdrawn 129 million yuan from the occupational risk fund, and the cumulative compensation limit of the occupational insurance purchased was 1.25 billion yuan. The relevant occupational insurance can cover the civil liability caused by audit failure.
5. Independence and integrity record
In the past three years, Lixin has been subject to criminal punishment, administrative punishment once, supervision and management measures 24 times, self-discipline and supervision measures and disciplinary punishment twice for its practice behavior, involving 63 employees.
(II) project member information
1. Personnel information
Certified public accountants begin to engage in the practice of the company’s project name in the exchange, practice time of listed companies, practice time of the company, and provide audit time service time
Project partner Zhang Aiguo 19951999 20122019
Signature: Certified Public Accountant sun Shuping 20001999 2012/
Quality control reviewed by Liu Jing 20092021 2021
(1) Mr. Zhang Aiguo, the project partner, has signed the audit reports of several listed companies in recent three years, including Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , Nanjing Gaoke Company Limited(600064) , Wuxi Rural Commercial Bank Co.Ltd(600908) , Jiangsu Changshu Rural Commercial Bank Co.Ltd(601128) , Jiangsu Maysta Chemical Co.Ltd(603041) , Jiangsu Seagull Cooling Tower Co.Ltd(603269) , and has not worked part-time in other units. (2) Ms. sun Shuping, the signatory certified public accountant, has signed the audit report of Nanjing Securities Co.Ltd(601990) 1 listed company in recent three years and has not worked part-time in other units. (3) Ms. Liu Jing, the reviewer of quality control, has not reviewed the audit reports of Listed Companies in recent three years and has not worked part-time in other units.
2. Record of the independence and integrity of the above relevant personnel.
The project partner, the signing certified public accountant and the quality control reviewer do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants. The above personnel have no bad records in the past three years.
(III) audit fees
1. Audit fee pricing principle
Pricing is mainly based on the responsibility of professional services and the degree of professional technology investment, and comprehensively considering the experience and level of employees involved in the work, the corresponding charging rate and the working hours invested.
2. Year on year changes in audit fees
Increase or decrease in amount from 2021 to 2020 (%)
Financial report audit fee 91316 Zhejiang Qianjiang Motorcycle Co.Ltd(000913) 16000
Internal control audit fee 262 China Vanke Co.Ltd(000002) 1200000 23.58
Total 11751 Huaneng Power International Inc(600011) 2516000 4.44
2、 Procedures to be performed by the accounting firm to be renewed
(I) prior review opinions of the audit committee of the board of directors
Through prior review of relevant materials and professional judgment, the audit committee of the board of directors issued the following opinions: Lixin Certified Public Accountants (special general partnership) has due professional competence, certain investor protection ability, independence and good faith; In the audit work of the company in 2021 and previous years, he can abide by the code of professional ethics, carry out the audit work in accordance with relevant regulations, and the relevant audit opinions are objective and fair; It is suggested that the board of directors of the company continue to appoint Lixin Certified Public Accountants (special general partnership) as the audit institution of the company’s financial report and internal control in 2022 for a period of one year, and the audit fee shall be determined by both parties through consultation according to the audit workload; And agreed to submit the proposal to the 14th meeting of the seventh board of directors for deliberation.
(II) prior approval and independent opinions of independent directors on the appointment of accounting firm
The prior approval opinions of independent directors are as follows: after careful and comprehensive review of the basic materials of Lixin Certified Public Accountants (special general partnership), we believe that Lixin Certified Public Accountants (special general partnership) has securities and futures business licenses; Have the professional competence and independence to provide audit services for listed companies, and be able to audit the company’s financial reports and internal control objectively and independently; We agreed to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the company’s 2022 financial report and internal control audit institution, and agreed to submit the proposal to the 14th meeting of the seventh board of directors for deliberation.
The independent opinions of the independent directors are as follows: the review procedure of the company’s renewed appointment of Lixin Certified Public Accountants (special general partnership) is sufficient and appropriate, in line with the provisions of relevant laws and regulations; In addition, Lixin Certified Public Accountants (special general partnership) scrupulously performed its duties in providing the company with 2021 financial report and internal control audit services, followed the professional standards of independence, objectivity and impartiality, and the reports issued objectively and truly reflected the company’s financial status, operating results and the operation of internal control; At the same time, considering the continuity of audit, the company agreed to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the audit institution of the company’s financial report and internal control in 2022, and agreed to submit the proposal to the company’s 2021 annual general meeting for deliberation.
(III) deliberation and voting of the board of directors on the proposal related to the appointment of accounting firm
At the 14th meeting of the 7th board of directors held on March 2, 2022, the company considered and approved the proposal on renewing the appointment of Lixin Certified Public Accountants (special general partnership) as the audit institution of the company’s financial report in 2022 and the proposal on renewing the appointment of Lixin Certified Public Accountants (special general partnership) as the audit institution of the company’s internal control in 2022, We agree to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the auditor of the company’s financial report and internal control in 2022. There were 7 directors who should attend the meeting and 7 actually attended the meeting. Both proposals were passed by unanimous vote.
(IV) the appointment of an accounting firm needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation, and will take effect from the date of deliberation and approval by the general meeting of shareholders of the company.
It is hereby announced.
Jiangsu Kanion Pharmaceutical Co.Ltd(600557) board of directors March 3, 2022
